Novan, Inc. (NOVN): Price and Financial Metrics

Novan, Inc. (NOVN): $0.09

0.03 (-24.84%)

POWR Rating

Component Grades








NOVN Price/Volume Stats

Current price $0.09 52-week high $3.33
Prev. close $0.13 52-week low $0.08
Day low $0.08 Volume 7,190,000
Day high $0.14 Avg. volume 602,421
50-day MA $0.73 Dividend yield N/A
200-day MA $1.13 Market Cap 2.64M

NOVN Stock Price Chart Interactive Chart >

Novan, Inc. (NOVN) Company Bio

Novan, Inc. focuses on the development and commercialization of nitric oxide-based therapies in dermatology. Its lead product candidate is SB204, a cosmetically elegant topical gel that targets multiple mechanisms of action for the treatment of acne vulgaris. The company was founded in 2006 and is based in Durham, North Carolina.

NOVN Latest News Stream

Event/Time News Detail
Loading, please wait...

NOVN Latest Social Stream

Loading social stream, please wait...

View Full NOVN Social Stream

Latest NOVN News From Around the Web

Below are the latest news stories about NOVAN INC that investors may wish to consider to help them evaluate NOVN as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today!

William White on InvestorPlace | June 29, 2023

Investors Holding Back On Novan, Inc. (NASDAQ:NOVN)

Novan, Inc.'s ( NASDAQ:NOVN ) price-to-sales (or "P/S") ratio of 1.1x might make it look like a buy right now compared...

Yahoo | June 7, 2023

Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders

DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2023 Annual Meeting of Stockholders (“ASM”) being held on Tuesday, June 6, 2023 at 9:30 a.m. Eastern Time in a virtual format. The Company also announced that its Chairman, President and CEO, Paula Brown Stafford, will provide a corporate update on the Company after the conclusion of the ASM, including the Company’s current

Yahoo | June 5, 2023

Novan Focuses Strategic Direction and Announces Restructuring

– Company directing resources on the potential approval of berdazimer gel, 10.3% (SB206) for molluscum contagiosum – – Process to explore a sale or out-license of commercial assets or other business transaction continues – – Continued progress toward PDUFA goal date of January 5, 2024, for berdazimer gel, 10.3% – DURHAM, N.C., May 31, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that following an evaluation of its commercial and developmental st

Yahoo | May 31, 2023

NOVN: Counting Down to PDUFA

By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT 1Q:23 Financial and Operational Results On May 15th, 2023, Novan Inc. (NASDAQ:NOVN) reported 1Q:23 financial and operational results in a press release and in the filing of Form 10-Q . A conference call and webcast were subsequently held to update investors on recent developments. The call highlighted the performance of the

Yahoo | May 16, 2023

Read More 'NOVN' Stories Here

NOVN Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year -82.69%
3-year -99.13%
5-year -99.65%
2023 0.00%
2022 -64.99%
2021 -48.71%
2020 -74.27%
2019 280.72%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!